Plasma calcium (Ca 2+ ) is maintained by amending the release of parathyroid hormone and through direct effects of the Ca 2+ sensing receptor (CaSR) in the renal tubule. Combined, these mechanisms alter intestinal Ca 2+ absorption by modulating 1,25-dihydroxy vitamin D3 production, bone resorption, and renal Ca 2+ excretion. The CaSR is a therapeutic target in the treatment of secondary hyperparathyroidism and hypocalcemia a common complication of calcimimetic therapy. The CaSR is also expressed in intestinal epithelium, however, a direct role in regulating local intestinal Ca 2+ absorption is unknown. Chronic CaSR activation decreased expression of genes involved in Ca 2+ absorption. In Ussing chambers, increasing extracellular Ca 2+ or basolateral application of the calcimimetic cinacalcet decreased net Ca 2+ absorption across intestinal preparations acutely. Conversely, Ca 2+ absorption increased with decreasing extracellular Ca 2+ concentration. These responses were absent in mice expressing a non-functional TRPV6, TRPV6 D541A . Cinacalcet also attenuated Ca 2+ fluxes through TRPV6 in Xenopus oocytes when co-expressed with the CaSR. Moreover, the phospholipase C inhibitor, U73122, prevented cinacalcet-mediated inhibition of Ca 2+ flux. These results reveal a regulatory pathway whereby activation of the CaSR in the basolateral membrane of the intestine directly attenuates local Ca 2+ absorption via TRPV6 to prevent hypercalcemia and help explain how calcimimetics induce hypocalcemia.
ABSTRACT
. This direct sensing of extracellular Ca 2+ occurs, at least in part, by the 7-transmembrane G-protein coupled Ca 2+ sensing receptor (CaSR) (7) .
PTH release from the parathyroid gland increases plasma Ca 2+ levels through direct effects on the nephron and bone, and indirectly on the intestine via stimulation of renal CYP27B1 activity, which catalyzes the synthesis of 1, 25 [OH] 2 D 3 (8) (9) (10) (11) . PTH secretion is regulated by the CaSR, where increased extracellular Ca 2+ activates the receptor, inhibiting release of PTH (12) (13) (14) and hence formation of 1, 25 [OH] 2 D 3 . In the thick ascending limb (TAL), blood Ca 2+ concentration is also sensed by the basolateral CaSR, which directly signals to decrease Ca 2+ reabsorption in that nephron segment (15) (16) (17) (18) . Conversely, PTH stimulates Ca 2+ absorption from the TAL (18, 19) and transcellular Ca 2+ reabsorption from the distal convoluted tubule (DCT) and connecting tubule (CNT) (20) (21) (22) . These studies highlight how the renal tubule responds to both endocrine regulation, and also directly senses extracellular Ca 2+ , to amend Ca 2+ reabsorption thereby preventing hypercalcemia.
The duodenum, cecum and proximal colon are sites of significant intestinal transcellular Ca 2+ absorption (23, 24 (15) . In addition, S100g and Atp2b1 expression was reduced in the cecum of cinacalcet treated mice ( Figure 1H ), and all genes involved in transcellular Ca 2+ absorption were decreased in the proximal colon of cinacalcet treated animals ( Figure 1I ). Figure 2 ). Figure 3A displays The CaSR is expressed throughout rodent and human intestine (32, (40) (41) (42) , including in both the apical and basolateral membranes of proximal colonocytes (30) (31) (32) . We confirmed intestinal CaSR expression by measuring mRNA via quantitative real-time PCR ( Figure 4A ).
RESULTS

Activation of an intestinal
Next, to determine whether apical and/or basolateral Ca 2+ sensing mediates decreased transcellular Ca 2+ absorption, we measured net Ca 2+ flux as above, but applied cinacalcet to either the basolateral or the apical hemi-chamber. Apical application of cinacalcet did not alter net Ca 2+ flux ( Figure 4B ). In contrast, basolateral treatment significantly decreased net Ca 2+ flux ( Figure 4C ). Moreover, basolateral application of cinacalcet attenuated net Ca 2+ flux across the duodenum and the cecum, other sites of transcellular Ca 2+ absorption ( Figure S1 ). These data are consistent with basolateral CaSR signalling decreasing transcellular intestinal Ca 2+ absorption. To understand how the CaSR may confer acute inhibition of Ca 2+ flux through TRPV6, we sought to reconstitute the system in vitro. To this end, we expressed human TRPV6 and the CaSR in Xenopus oocytes and measured Ca 2+ currents (I Ca ). We choose this system to study the effect of CaSR activation on TRPV6 activity as it lacks endogenous G-protein coupled receptors that are often present in mammalian cell culture models. Oocytes expressing TRPV6 alone failed to decrease I Ca after incubation with cinacalcet ( Figure S2 ) (44 
TRPV6 mediated Ca 2+ absorption is attenuated by CaSR activation
CaSR activation inhibits transcellular Ca 2+ absorption via phospholipase C activation
Finally, the involvement of PLC in CaSR-mediated regulation of TRPV6 was investigated in the proximal colon ex vivo. To this end, we again employed the PLC inhibitor U73122 in combination with cinacalcet in Ussing chambers. For these experiments, we had a similar condition A (control condition), but for condition B, we administered either cinacalcet + vehicle (DMSO) or cinacalcet + U73122. The cinacalcet/vehicle treated group displayed a significant decrease in net Ca 2+ flux ( Figure 6D ). However, co-incubation with the PLC inhibitor prevented the inhibitory effect of cinacalcet ( Figure 6D ). These data are in agreement with our in vitro data ( Figure 6 ), and together infer that basolateral CaSR activation decreases transcellular Ca 2+ transport through TRPV6 via a CaSR-induced activation of PLC in the proximal colon.
DISCUSSION
The CaSR is expressed throughout the intestine, however, a direct role for the intestinal CaSR in maintaining Ca 2+ homeostasis has not been described (7, 33 homeostasis.
The administration of cinacalcet to dialysis patients often causes hypocalcemia (69) (70) (71) .
This has been attributed to hungry bone syndrome, via rapid lowering of plasma PTH. Our work provides an alternative explanation for this observation. Cinacalcet administration would not only attenuate release of PTH from the parathyroid, but also inhibit Ca 2+ absorption from the intestine, thereby lowering plasma Ca 2+ levels.
In conclusion, we demonstrate a Ca 2+ -sensing mechanism present in proximal large bowel that regulates Ca 2+ absorption through a transcellular pathway, both acutely and chronically. The transcellular pathway mediating this effect relies on apical Ca 2+ influx through cinacalcet (5-days) were performed and described previously (15) .
Real-time quantitative PCR
Following euthanasia, the duodenum, cecum, and proximal colon were collected as previously described (25) . Total RNA was isolated using TRIzol Reagent and reverse transcribed into cDNA using Random Primers and SuperScript II reverse transcriptase (all from Invitrogen, Carlsbad, CA). Primers and probes (Integrated DNA Technologies, San Diego, CA) designed for TRPV6 (Trpv6), CABP9K (S100g), NCX1 (Slc8a1), PMCA1b (Atp2b1), and CaSR (CaSR) were used to quantify expression levels with a ABI Prism 7900 HT Sequence Detection System (Applied Biosystems, Foster City, CA). Table S1 ).
Ussing chamber experiments
Xenopus oocyte expression and two-electrode voltage clamp
The preparation of Xenopus oocytes and the two-electrode voltage clamp experiments were performed as previously (73) . Capped RNA of human TRPV6 [accession #: NM_018646; generated using in vitro transcription with mMESSAGE mMACHINE kit (Ambion, Austin, TX)]
and human CaSR cDNA (Origene, Rockville, MD, Cat #RC211229) were injected into Xenopus oocytes. Two-days post injection, whole-cell Ca 2+ currents of oocytes were recorded at room temperature in a standard extracellular solution containing 100 mM NaCl, 2 mM KCl, 1 mM amplifier and Digidata 1322A AD/DA converter (Molecular Devices, Union City, CA) were used to obtain the currents. pClamp 9 software (Axon Instruments, Union City, CA) was used for data acquisition and analysis. Currents and voltages were digitally recorded at 200 ms/sample and filtered at 2 kHz through a Bessel filter. Sigma Plot 14 (Systat Software, San Jose, CA) was used for plotting data.
Oocytes surface protein expression was determined with a biotinylation assay as previously (73) . In short, the oocytes were incubated with 0.5 mg/mL sulfo-NHS-SS-Biotin 
Statistics
Data are presented as means ± standard error of the mean (SEM), and all data reported are based on measurements made on > 6 different animals (minimum 3 males and 3 females 
